According to the UnivDatos Market Insights Analysis, the surge in the incidence of lung cancer patients and the rise in demand for AI will drive the global scenario of Lung Cancer Screening Software. As per their “Lung Cancer Screening Software Market” report, the global market was valued at USD 35 million in 2023, growing at a CAGR of about 19% during the forecast period from 2024...